Fig. 4From: Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysisComparison of two groups of studies: IPF versus non-IPF for standardised FVC change in response to therapyBack to article page